Inceptor Bio announced it raised $2.63 Million in an initial filing from an offering of $13.9 Million
Inceptor Bio announced it raised $2.63 Million in an initial filing from an offering of $13.9 Million
10/20/22, 3:24 PM
Location
morrisvilleMoney raised
$2.63 million
Industry
biotechnology
health care
Company Info
Location
morrisville, north carolina, united states
Additional Info
Inceptor Bio is a clinical-stage biotech company pioneering next-generation cell therapies to cure cancer. Our proprietary OUTLAST™ platform reprograms T cells into persistent, stem-like cells capable of thriving in the hostile tumor microenvironment.